长药控股
(300391)
| 流通市值：13.17亿 | | | 总市值：13.17亿 |
| 流通股本：3.50亿 | | | 总股本：3.50亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 6,736,442.47 | 10,060,539.75 | 8,550,006.63 | 15,203,300.56 |
| 应收票据及应收账款 | 1,521,898,918.72 | 1,520,312,110.34 | 1,603,853,809.9 | 1,639,256,949.32 |
| 其中：应收票据 | - | - | - | 100,000 |
| 应收账款 | 1,521,898,918.72 | 1,520,312,110.34 | 1,603,853,809.9 | 1,639,156,949.32 |
| 应收款项融资 | - | 95,000 | - | 238,105.6 |
| 预付款项 | 126,690,564 | 126,371,398.87 | 145,416,454.2 | 120,759,307.99 |
| 其他应收款合计 | 73,937,024.55 | 73,220,153.25 | 259,178,496.97 | 243,940,881.13 |
| 存货 | 45,420,832.36 | 54,152,171.68 | 53,704,389.97 | 51,858,189.15 |
| 合同资产 | 5,276,585 | 845,310 | 6,919,139.43 | 6,919,139.43 |
| 其他流动资产 | 44,074,543.65 | 50,405,888.8 | 43,378,715.71 | 50,449,066.3 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,824,034,910.75 | 1,835,462,572.69 | 2,121,001,012.81 | 2,128,624,939.48 |
| 非流动资产: | | | | |
| 固定资产 | 741,810,585.73 | 748,715,192.05 | 755,544,270.59 | 763,856,572.4 |
| 在建工程 | 196,079,457.12 | 189,248,247.61 | 194,784,131.88 | 184,817,733.21 |
| 生产性生物资产 | - | - | - | 1,948,213.07 |
| 使用权资产 | 6,096,289.4 | 6,449,351.66 | 8,784,934.15 | 11,766,478.14 |
| 无形资产 | 97,196,130.68 | 97,829,636.11 | 98,504,182.5 | 99,183,728.74 |
| 商誉 | 208,626,653.9 | 208,626,653.9 | 236,069,896.4 | 236,069,896.4 |
| 递延所得税资产 | 16,466,500.21 | 16,466,500.21 | 16,466,500.21 | 16,466,500.21 |
| 其他非流动资产 | 813,500 | 5,011,550 | 813,500 | 3,023,000 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,267,089,117.04 | 1,272,347,131.54 | 1,310,967,415.73 | 1,317,132,122.17 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,091,124,027.79 | 3,107,809,704.23 | 3,431,968,428.54 | 3,445,757,061.65 |
| 流动负债: | | | | |
| 短期借款 | 199,983,957.28 | 219,723,957.28 | 214,983,957.28 | 205,116,230.23 |
| 应付票据及应付账款 | 326,370,055.38 | 326,968,840.76 | 361,122,588.79 | 358,507,989.82 |
| 其中：应付票据 | 432,610.6 | 1,492,579.6 | 2,795,595.84 | 17,464,523.17 |
| 应付账款 | 325,937,444.78 | 325,476,261.16 | 358,326,992.95 | 341,043,466.65 |
| 合同负债 | 14,435,132.69 | 13,740,047.15 | 13,573,533.5 | 16,951,633.86 |
| 应付职工薪酬 | 25,905,222.42 | 26,596,796.64 | 22,113,085.38 | 18,519,841.36 |
| 应交税费 | 124,788,023.67 | 124,962,058.84 | 124,879,559.74 | 127,464,069.5 |
| 其他应付款合计 | 1,032,401,992.7 | 961,978,704.38 | 1,117,838,933.5 | 1,044,108,076.35 |
| 其中:应付利息 | 26,018,119.6 | 23,889,067.47 | 28,735,816.73 | 20,436,885.95 |
| 一年内到期的非流动负债 | 106,957,395.84 | 106,956,270.75 | 106,381,750.05 | 108,032,341.15 |
| 其他流动负债 | 538,078.48 | 538,078.48 | 553,147.54 | 1,723,441.47 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,831,379,858.46 | 1,781,464,754.28 | 1,961,446,555.78 | 1,880,423,623.74 |
| 非流动负债: | | | | |
| 长期借款 | 480,899,000 | 510,899,000 | 504,482,472.22 | 518,885,578.72 |
| 租赁负债 | 5,923,596.53 | 5,957,344.53 | 6,247,591.56 | 5,453,980.79 |
| 预计负债 | 12,954,720.81 | 11,039,939.98 | 676,450.5 | 676,450.5 |
| 递延收益 | 14,996,666.42 | 15,078,466.43 | 15,160,266.44 | 15,242,066.45 |
| 递延所得税负债 | 7,103,618.38 | 7,103,618.39 | 7,103,618.39 | 7,103,618.38 |
| 其他非流动负债 | 650,313.53 | 650,313.53 | 650,313.53 | 650,313.53 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 522,527,915.67 | 550,728,682.86 | 534,320,712.64 | 548,012,008.37 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,353,907,774.13 | 2,332,193,437.14 | 2,495,767,268.42 | 2,428,435,632.11 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 350,336,112 | 350,336,112 | 350,336,112 | 350,336,112 |
| 资本公积 | 788,172,222.03 | 788,172,222.03 | 788,172,222.03 | 788,172,222.03 |
| 盈余公积 | 18,358,424.24 | 18,358,424.24 | 18,358,424.24 | 18,358,424.24 |
| 未分配利润 | -1,142,716,415.97 | -1,114,318,748.05 | -1,009,251,591.25 | -961,745,688.98 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 14,150,342.3 | 42,548,010.22 | 147,615,167.02 | 195,121,069.29 |
| 少数股东权益 | 723,065,911.36 | 733,068,256.87 | 788,585,993.1 | 822,200,360.25 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 737,216,253.66 | 775,616,267.09 | 936,201,160.12 | 1,017,321,429.54 |
| 负债和股东权益合计 | 3,091,124,027.79 | 3,107,809,704.23 | 3,431,968,428.54 | 3,445,757,061.65 |
| 公告日期 | 2024-10-30 | 2024-08-30 | 2024-04-30 | 2024-04-30 |
| 审计意见(境内) | | | | 带强调事项段的无保留意见 |